Daniel M. Bell

All filings by Daniel M. Bell on record concern KOS Pharmaceuticals Inc. In total, 2 filings cover trades dated from 26 January 2006 to 13 December 2006.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 15 December 2006, reports a transaction of €2.7M in KOS Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.